'INTRANASAL DELIVERY TO IMPROVE THE PERFORMANCE OF CHILDREN SUFFERING FROM DYSLEXIA'

摘要

The invention discloses a pharmaceutical composition comprising therapeutically effective amount of stimulants, anti-motion drugs and nootropics, either alone or in combination, administered through, oral, intranasal or intravenous, for the treatment and/or management of dyslexia